Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine from Aug 6
4 years, 4 months ago

Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine from Aug 6

The Hindu  

Drug firm Zydus Cadila on Wednesday said the phase I clinical trial of its COVID-19 vaccine candidate, ZyCoV-D, has been completed and it will commence phase II clinical trials from August 6. “The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, 2020, has been well tolerated,” Cadila Healthcare, the listed entity of the group, said in a regulatory filing. We now begin the phase II clinical trials and look forward to evaluating the safety and immunogenicity of the vaccine in a larger population, he added. It got approval a few days after India’s first indigenous COVID-19 vaccine candidate COVAXIN, developed by city-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, got the nod for human clinical trials from the Drug Controller General of India Shares of Cadila Healthcare were trading at ₹407.20 apiece on BSE, up 1.08% from its previous close.

India Trial Trials Phase Vaccine Clinical Zydus Zydus Cadila Cadila I Clinical Trial  covid19  ii  trial  commence  vaccine  phase  clinical  cadila  safety  trials  zydus  aug

History of this topic

As Indians Choose to Ignore Booster Shots, Pace of Vaccine Testing Slows Down at Himachal Lab
2 years, 6 months ago

As Indians Choose to Ignore Booster Shots, Pace of Vaccine Testing Slows Down at Himachal Lab

News 18  

As India grapples to boost coverage of precaution dose, the pace of vaccine testing seems to be coming down at the country’s apex laboratory in Himachal Pradesh, News18.com has learnt. Currently, the lab is testing batches of Biological E’s Corbevax, which has been approved for kids starting 5 years and is awaiting more clearances for heterologous booster shot. THE CURIOUS …

India clears 2 vaccines for kids under 12 years
2 years, 7 months ago

India clears 2 vaccines for kids under 12 years

Hindustan Times  

India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children under the age of 12 years – a milestone move that paves the way for that cohort in the country to receive a vaccine shot against the disease for the first time. Currently, Bharat Biotech’s Covaxin, an inactivated …

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts
2 years, 10 months ago

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts

News 18  

Three vaccines – Covovax, Biological E’s jab Corbevax, and Zydus Cadila’s ZyCoV-D vaccine – approved last year by the Drug Controller General of India for emergency use are yet to be rolled out in the vaccination drive. Experts opine that now is the right time to roll out the vaccines as India has started immunizing adolescents and giving precautionary dose …

Only Covaxin for 15-18 year-olds, booster shots 9 months after second dose | Govt guidelines
2 years, 11 months ago

Only Covaxin for 15-18 year-olds, booster shots 9 months after second dose | Govt guidelines

India Today  

The government released official guidelines on Covid-19 vaccination for 15 to 18-year-olds as well as 'precaution doses' for frontline workers and people above the age of 60 years with co-morbidities on Monday. Over the weekend, Prime Minister Narendra Modi had announced that children in the 15-18 age group would begin receiving Covid-19 vaccines from January 3 onwards and booster shots …

India's First Needle-free Covid Vaccine to Hit Market: Here's All About the 3-dose ZyCov-D Jab
3 years ago

India's First Needle-free Covid Vaccine to Hit Market: Here's All About the 3-dose ZyCov-D Jab

News 18  

After the first indigenous Covid-19 vaccine, Covaxin, India is all set to roll out its second made-in-India vaccine. It is a needle-free vaccine administered in three doses, tested at Central Drug Laboratory at Kasauli in Himachal Pradesh and manufactured by Cadila Healthcare. The official further said the company’s vaccine is based on “plug and play technology” as it can be …

ZyCoV-D, India’s First Covid Vaccine for Children Aged 12+, to be Administered Among Adults in 7 States First
3 years ago

ZyCoV-D, India’s First Covid Vaccine for Children Aged 12+, to be Administered Among Adults in 7 States First

News 18  

ZyCoV-D, the first Covid-19 vaccine to be cleared by India’s drug regulator for those aged 12 and above, will be administered to adults first, News18 has learnt. The Zydus Cadila shot will not be part of the national vaccination drive initially but will be introduced in seven states first, a top government official privy to the developments said. The ZyCoV-D …

2,37,530 Doses of Needle-free Covid Vaccine ZyCoV-D Released for Use from CDL after Testing
3 years ago

2,37,530 Doses of Needle-free Covid Vaccine ZyCoV-D Released for Use from CDL after Testing

News 18  

Seven batches comprising 2,37,530 doses of India’s first DNA vaccine ZyCoV-D to fight Covid, manufactured by Cadila Healthcare, have been released after being tested by the Central Drug Laboratory in Kasauli. In addition to that, 466 batches of Covaxin, 549 of Covishield, seven of Janssen and 24 batches of Sputnik V have also been released, Dr Arun Bhardwaj, director, CDL, …

Centre Orders 1 Crore Shots of Zydus Cadila's Covid-19 Vaccine at Rs 265 Per Dose
3 years, 1 month ago

Centre Orders 1 Crore Shots of Zydus Cadila's Covid-19 Vaccine at Rs 265 Per Dose

News 18  

The central government has placed an order of one crore doses of Zydus Cadila’s ZyCoV-D, the world’s first plasmid DNA vaccine, at Rs 265 per dose, the company said in a statement on Monday. The needle-free applicator will cost Rs 93 per dose, excluding GST, the company said, adding that the pricing has been decided in consultation with the Centre. …

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine
3 years, 1 month ago

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine

Live Mint  

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday. "The Centre has already placed a purchase order with Zydus Cadila for supply of one crore doses of ZyCoV-D, each costing …

Zydus Cadila Agrees to Reduce Covid Vaccine Price to Rs 265 a Dose, Final Decision Soon: Sources
3 years, 1 month ago

Zydus Cadila Agrees to Reduce Covid Vaccine Price to Rs 265 a Dose, Final Decision Soon: Sources

News 18  

Zydus Cadila has agreed to bring down the price of its Covid-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday. To administer the needle-free ZyCov-D vaccine, a disposable painless jet applicator costing Rs 93 is required for each dose, which would take the …

Zydus Cadila agrees to reduce its Covid vaccine price to ₹265 a dose, final decision soon: Report
3 years, 1 month ago

Zydus Cadila agrees to reduce its Covid vaccine price to ₹265 a dose, final decision soon: Report

Live Mint  

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to ₹265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday. To administer the needle-free ZyCov-D vaccine, a disposable painless jet applicator costing ₹93 is required for each dose, which would take the price to …

60 lakh ZyCoV-D's Needle-free Vaccine Doses Ready: Report
3 years, 2 months ago

60 lakh ZyCoV-D's Needle-free Vaccine Doses Ready: Report

News 18  

A day after Bharat Biotech’s Covaxin was approved for emergency use for children in the 2 to 18 age group, there’s more good news. A total of 60 lakh doses of Zydus Cadila’s ZyCoV-D vaccine are ready after production, according to top government sources quoted in a report by news agency Asian News International. According to the ANI report, in …

Abiding By Centre's Supply Principle, Kids’ Vaccine ZyCoV-D To Be Supplied To Private Hospitals
3 years, 2 months ago

Abiding By Centre's Supply Principle, Kids’ Vaccine ZyCoV-D To Be Supplied To Private Hospitals

News 18  

The first vaccine approved for use among children in the age group of 12-17 in India namely ZyCoV-D, will also be made available to private sector hospitals across the country as per reports. “If there are buyers, up to 25 lakh doses of the ZyCoV-D would be made available to private sector hospitals every month as the initial monthly vaccine …

National Rollout of Zydus Cadila’s Vaccine As Early as Oct 15, Says NTAGI Chief, Final Checks On
3 years, 2 months ago

National Rollout of Zydus Cadila’s Vaccine As Early as Oct 15, Says NTAGI Chief, Final Checks On

News 18  

With the national rollout of Zydus Cadila’s Covid vaccine, ZyCoV-D just 2 weeks away, different batches of ZyCoV-D are undergoing a final round of quality checks at the vaccine testing laboratory in Himachal Pradesh. Talking to TOI, NK Arora, chairman of the Centre’s Covid working group of the National Technical Advisory Group on Immunisation expressed that if everything works out …

Zydus Cadila Quotes Rs 1,900 for Its Covid Vaccine Shot; Govt in Talks to Curtail Price
3 years, 2 months ago

Zydus Cadila Quotes Rs 1,900 for Its Covid Vaccine Shot; Govt in Talks to Curtail Price

News 18  

Around 1.5 lakh doses of Zydus Cadila’s ZyCoV-D vaccine have cleared the quality test at Central Drugs Laboratory, in Kasauli, Himachal Pradesh, sources told CNN-News18, adding that the government is currently in negotiation with the manufacturers to bring down the commercial price of the jab. It has taken longer for the government and manufacturers to negotiate the price of the …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 2 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive
3 years, 2 months ago

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive

News 18  

Zydus Cadila?s Covid-19 DNA vaccine will be?introduced? On August 20, DCGI approved Zydus Cadila vaccine for emergency use in adults and children aged 12 years and above. LIVE Updates At the weekly health ministry briefing, Health Secretary Rajesh Bhushan said:?Zydus vaccine will be introduced very soon. Last week, responding to a question at a press conference, NITI Aayog Member Dr …

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry
3 years, 2 months ago

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry

India Today  

The health ministry has said that Zydus Cadila's Covid-19 vaccine would be introduced in the national vaccination programme very shortly. Union health secretary Rajesh Bhushan said, “Zydus Cadila vaccine has been given approval. We are in conversation with the manufacturers about the pricing of the vaccine.” “Since it is a 3-dose vaccine, it would have differential pricing than the currently …

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October
3 years, 2 months ago

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October

Firstpost  

The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi The Central government, along with pharmaceutical company Zydus Cadila is likely to take a call on the pricing of ZyCov-D, the world’s first DNA vaccine to fight COVID-19, with the launch likely on 2 …

Modi Govt's Oct Bonanza: 1 Crore Doses of Zydus Cadila’s Covid Vaccine to Hit Markets Next Month
3 years, 3 months ago

Modi Govt's Oct Bonanza: 1 Crore Doses of Zydus Cadila’s Covid Vaccine to Hit Markets Next Month

News 18  

New Delhi: The Narendra Modi government at the Centre is planning to roll out Zydus Cadila’s Covid-19 vaccine, ZyCoVD, by the end of October, News18 has learnt. The government is expecting the delivery of one crore doses of DNA vaccine which can also be administered to adolescents aged between 12 and 17. In the coming months, India may also add …

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources
3 years, 3 months ago

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources

India TV News  

Zydus Cadila's needle-free coronavirus vaccine ZyCoV-D is likely to be launched in early October, according to sources. Indigenously developed Zydus Cadila's ZyCoV-D had received approval for Emergency Use Authorisation from the drug regulator two weeks ago, making it the first vaccine in the country which would be administered in the age group of 12-18 years. On the kind of negotiations …

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences
3 years, 3 months ago

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

The Hindu  

The Drugs Controller General of India on September 3 granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said. The phase-I clinical trial will be conducted to evaluate safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy volunteers according to protocol, they …

'ZyCoV-D Will be as Affordable as Our Other Products, Market Launch Likely by Sept-end': Zydus Group MD
3 years, 3 months ago

'ZyCoV-D Will be as Affordable as Our Other Products, Market Launch Likely by Sept-end': Zydus Group MD

News 18  

Price of India’s second home-grown Covid-19 vaccine, ZyCoV-D, will be decided basis the technology, capacity and volume, and it will be “affordable”, Dr Sharvil Patel, managing director of Zydus Group, the company manufacturing the vaccine, told News18.com. “Throughout the pandemic, Zydus has provided affordable therapeutics, diagnostics and preventives and ZyCoV-D will be no different.” ZyCoV-D — which is the world’s …

Recruitment of Volunteers for Trial of Covid Vaccine Covovax on Children Begins
3 years, 3 months ago

Recruitment of Volunteers for Trial of Covid Vaccine Covovax on Children Begins

News 18  

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research here. Indigenously developed Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the …

ZyCoV-D vaccine safe and effective for adolescents, says expert
3 years, 3 months ago

ZyCoV-D vaccine safe and effective for adolescents, says expert

The Hindu  

Arora, a senior member of National COVID-19 Task Force and Advisor, national AEFI committee, speaks to The Hindu about the ZyCoV-D vaccine — the world’s first plasmid DNA vaccine for human use — and how it could be the beginning of a vaccine revolution. ZyCoV-D vaccine is the world’s first plasmid DNA vaccine for human use. Any new vaccine is …

NTAGI to Meet This Week to Introduce Zycov-D in Covid-19 Immunisation Plan
3 years, 4 months ago

NTAGI to Meet This Week to Introduce Zycov-D in Covid-19 Immunisation Plan

News 18  

The National Technical Advisory Group on Immunisation will hold a key meet this week to outline the roadmap for the introduction of DNA-based Zydus Cadila’s vaccine in the general population. It is expected that the meet will help prepare a plan on how to inculcate and introduce the Zycov-D vaccine in India’s immunisation programme. The official added that adolescents with …

Zydus Cadila to start making 1 crore doses of Covid vaccine by October
3 years, 4 months ago

Zydus Cadila to start making 1 crore doses of Covid vaccine by October

India Today  

Zydus Cadila announced on Saturday that they will start producing one crore doses of Covid-19 vaccine by October. When asked about the government projection that there would be five crore doses of Zydus Cadila vaccine in August, Dr Sharvil Patel, Managing Director of Zydus Cadila, said, “We faced a delay of 45 days to commission the new plant,” and added, …

Zydus Cadila Becomes 6th Weapon in India's Armour Against Covid
3 years, 4 months ago

Zydus Cadila Becomes 6th Weapon in India's Armour Against Covid

News 18  

Indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D on Friday received Emergency Use Authorisation from the Drug Controller General of India. Johnson & Johnson Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said. Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. The SII is …

Zycov-D, India’s first COVID-19 vaccine for those above 12, gets nod
3 years, 4 months ago

Zycov-D, India’s first COVID-19 vaccine for those above 12, gets nod

The Hindu  

The Drug Controller General has granted emergency approval to the Zycov-D, a COVID-19 vaccine developed by the Ahmedabad based Zydus Cadilla group, on Friday, making it the first vaccine in India that can be administered to adults as well as those 12 and above. This vaccine had already exhibited robust immunogenicity and tolerability and safety profile in the adaptive Phase …

Zydus Cadila's 3-dose Jab Approved; India Gets its First Vaccine for Children 12 Years and Above
3 years, 4 months ago

Zydus Cadila's 3-dose Jab Approved; India Gets its First Vaccine for Children 12 Years and Above

News 18  

Indian drug regulator DCGI on Friday approved Zydus Cadila’s three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorized for use in the country. After news of the approval, Prime Minister Narendra Modi and Union Health Minister Mansukh Mandaviya lauded India’s fight against Covid-19, with another weapon in …

ZyCoV-D, World's 1st DNA Plasmid Covid-19 Vaccine Gets Approval: All About India's 2nd Homegrown Jab
3 years, 4 months ago

ZyCoV-D, World's 1st DNA Plasmid Covid-19 Vaccine Gets Approval: All About India's 2nd Homegrown Jab

News 18  

ZyCoV-D, a three-dose Covid-19 vaccine by Ahmedabad-based pharmaceutical firm Cadila Healthcare, was on Friday received approval for Emergency Use Authorisation from the Drug Controller General of India and it will be administered to people 12 years and above. Zydus Cadila had earlier said that they can launch their three-dose plasmid DNA Covid-19 vaccine within two months of receiving the approval. …

Zydus Cadila's 3-dose Covid Vaccine ZyCov-D Gets Govt Panel Nod
3 years, 4 months ago

Zydus Cadila's 3-dose Covid Vaccine ZyCov-D Gets Govt Panel Nod

News 18  

The Indian drug regulator?s subject expert committee has recommended emergency use approval for Zydus Cadila?s three-dose COVID-19 vaccine. The generic drugmaker, listed as Cadila Healthcare Ltd, applied for the authorisation of the vaccine ZyCoV-D on July 1, based on an efficacy rate of 66.6% in a late-stage trial of more than 28,000 volunteers nationwide. Zydus Cadila had earlier said that …

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya
3 years, 4 months ago

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya

Firstpost  

AIIMS Director Dr Randeep Guleria recently said data of phase two and three trials of Bharat Biotech’s Covaxin on 2 to 18 years age group is expected by September Ahmedabad: Union Health Minister Mansukh Mandaviya on Thursday said results of ongoing research for the development of COVID-19 vaccines for children may arrive next month and the antidote may be launched …

Zydus Cadila's Covid vaccine gets emergency use nod, will be first jab for 12-18 year olds
3 years, 4 months ago

Zydus Cadila's Covid vaccine gets emergency use nod, will be first jab for 12-18 year olds

India Today  

Vaccine maker Zydus Cadila's three-dose Covid vaccine ZyCoV-D has got DCGI approval for emergency use authorisation. The Subject Expert Committee of Central Drugs Standard Control Organisation had recommended an emergency use authorization for Zydus Cadila's three-dose Covid-19 vaccine, ZyCoV-D. ZyCoV-D is a three-dose, intradermal vaccine, which is applied using a needle-free system, Tropis, which can also lead to a significant …

When will Covid vaccines be available for children? Health Minister responds
3 years, 4 months ago

When will Covid vaccines be available for children? Health Minister responds

India TV News  

Union Health Minister Mansukh Mandaviya on Thursday said that the results of an ongoing research for development of Covid-19 vaccines for children may arrive next month and the antidote may be launched "very soon". Recently, AIIMS Director Dr. Randeep Guleria had said that data of phase two and three trials of Bharat Biotech's Covaxin on 2 to 18 years age …

COVID-19 vaccines for children may be available by September: NIV director
3 years, 4 months ago

COVID-19 vaccines for children may be available by September: NIV director

India TV News  

Vaccines for children may be available by September and the trials for inoculating those between 2 to 18 years are underway, Priya Abraham, Director of the National Institute of Virology has said. In an interview to India Science, an OTT platform of the Department of Science and Technology, Abraham said phase 2/3 clinical trials are in process for those between …

Covid Vaccine Tracker: J&J Doses Expected to Arrive India in Nov-Dec, Zydus Cadila Next
3 years, 4 months ago

Covid Vaccine Tracker: J&J Doses Expected to Arrive India in Nov-Dec, Zydus Cadila Next

News 18  

India is expected to get first doses of the single-shot vaccine of Johnson & Johnson in November or December this year, a top government source said, after the Centre had last week granted Emergency Use Authorization to the foreign Covid-19 vaccine manufacturer. The next coronavirus vaccine that the government is expecting to arrive after Covishield, Covaxin and Sputnik is Zydus …

Zydus Cadila's Covid vaccine to get Govt's approval this week: Report
3 years, 4 months ago

Zydus Cadila's Covid vaccine to get Govt's approval this week: Report

India TV News  

Zydus Cadila Vaccine News: The Government is likely to give its nod for emergency use authorisation to Zydus Cadila's needle-free Covid-19 vaccine 'ZyCoV-D' this week, news agency ANI reported on Monday. 'ZyCoV-D' will be a three-dose vaccine and the companys plans to manufacture 10-12 crore doses annually, Zydus Cadila had said in a statement last month. Last week, Union Health …

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds
3 years, 4 months ago

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds

India Today  

The Covid vaccine candidate of Zydus Cadila is likely to get emergency use authorisation from the Centre this week, sources told India Today. The company has conducted the largest clinical trial for its Covid-19 vaccine in India, including on the adolescent population in the 12-18 years age group. If approved, ZyCoV-D would be the first vaccine in India for the …

Zydus Cadila to Submit Additional Data on Covid Vaccine to DGCI This Week: Sources
3 years, 5 months ago

Zydus Cadila to Submit Additional Data on Covid Vaccine to DGCI This Week: Sources

News 18  

The Gujarat-based pharma company Zydus Cadila is expected to provide additional data related to immunogenicity and safety of its vaccinate candidate ZyCoV-D to the Drugs Controller General of India this week, according to sources. Zydus’ three-dose vaccine was reported to be 66.6 per cent effective against symptomatic Covid cases and 100 per cent effective for moderate infection. NITI Aayog member …

Covid-19 vaccine trial for children: Second dose to kids aged 2-6 years to be given next week
3 years, 5 months ago

Covid-19 vaccine trial for children: Second dose to kids aged 2-6 years to be given next week

India Today  

The second dose of Bharat Biotech's Covid-19 vaccine, Covaxin for children aged 2-6 years, is likely to be administered to those participating in the trials next week, the sources said. The second dose of Covaxin has already been given to children between aged 6-12 years, said sources, at the All India Institute of Medical Sciences in New Delhi, which is …

Zydus Cadila’s Covid vaccines for children may be available soon: Govt to court
3 years, 5 months ago

Zydus Cadila’s Covid vaccines for children may be available soon: Govt to court

Live Mint  

Indian drugmaker Zydus Cadila's Covid-19 vaccine may be available for children in the 12 to 18 age group soon, the central government has told Delhi High Court. "Zydus Cadila has concluded its trial for children between the age group of 12 to 18 and is subject to statutory permissions," the Centre said in an affidavit submitted on Friday. Further, the …

Zydus Cadila's Covid vaccine for 12-18 year olds soon, clinical trials done: Centre to Delhi HC
3 years, 5 months ago

Zydus Cadila's Covid vaccine for 12-18 year olds soon, clinical trials done: Centre to Delhi HC

India Today  

The Centre informed the Delhi High Court that Zydus Cadila has concluded the clinical trial of its DNA-based Covid-19 vaccine ZyCoV-D for the 12-18 age group and that it could soon be available. In an affidavit dated July 15, Satyendra Singh, Under Secretary to the Ministry of Health and Family Welfare, said, "It is submitted that Zydus Cadila which is …

DCGI Recommendation On Zydus Vaccine Likely Soon, Will Allow Doses for Kids if Found Safe: Govt
3 years, 5 months ago

DCGI Recommendation On Zydus Vaccine Likely Soon, Will Allow Doses for Kids if Found Safe: Govt

News 18  

The recommendations of the Drugs Controller General of India on Zydus Cadila’s ZyCoV-D three-dose vaccine are likely to be out soon, NITI Aayog member VK Paul said on Friday. Zydus has said the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in …

Decision on Zydus needle-free Covid vaccine in few days. What you need to know
3 years, 5 months ago

Decision on Zydus needle-free Covid vaccine in few days. What you need to know

Live Mint  

Ahmadabad-based drugmaker Zydus Cadila's application for the emergency use authorization of its Covid-19 vaccine will likely be taken up by a Subject Expert Committee of India's drug regulator this week, reported news agency Reuters, citing an Economic Times report. The company had last week submitted an application to the Drugs Controller General of India, seeking authorisation for its ZyCoV-D three-dose …

Can Launch Vaccine Within 2 Months If Approved, Says Zydus Cadila on World's 1st Plasmid DNA Shot
3 years, 5 months ago

Can Launch Vaccine Within 2 Months If Approved, Says Zydus Cadila on World's 1st Plasmid DNA Shot

News 18  

Ahmedabad-based pharmaceutical firm Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the world’s first Plasmid DNA vaccine. According to Dr Sharvil Patel, Managing Director, Cadila Healthcare, the vaccine has shown primary efficacy of 66.6 per cent for symptomatic RT-PCR positive cases. “The Vaccine has shown primary efficacy of 66.6 per cent for symptomatic …

As Zydus Cadila Seeks Nod for World’s Ist Plasmid DNA Shot, Here’s Everything About its Science
3 years, 5 months ago

As Zydus Cadila Seeks Nod for World’s Ist Plasmid DNA Shot, Here’s Everything About its Science

News 18  

Ahmedabad-based pharmaceutical firm Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the world’s first Plasmid DNA vaccine. Zydus claims its vaccine is 66.6 per cent effective against symptomatic Covid cases and 100 per cent for moderate disease. Purified plasmid DNA containing an antigen’s coding sequences and the necessary regulatory elements to express them …

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India
3 years, 5 months ago

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

India TV News  

Zydus Cadila has applied for Emergency Use Authorisation nod from the Drugs Controller General of India for the launch of its DNA vaccine, ZyCoV-D, for 12 years and above. If DGCA grants approval, ZyCoV-D will join Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russia's Sputnik V vaccines to be authorized for emergency use in India. The company said …

Zydus Cadila seeks emergency use nod for covid vaccine, also tested in 12-18 year-olds
3 years, 5 months ago

Zydus Cadila seeks emergency use nod for covid vaccine, also tested in 12-18 year-olds

Live Mint  

Zydus Cadila today announced that the company has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19. This was also the first time that any COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India. As the first ever plasmid …

'Needle-free' Zydus Cadila vaccine to come with an applicator. Company to roll out 5 crore doses by year-end
3 years, 5 months ago

'Needle-free' Zydus Cadila vaccine to come with an applicator. Company to roll out 5 crore doses by year-end

India Today  

The 'needle-free' Zydus Cadila vaccine will come with an applicator, which the company has developed with PharmaJet. A study done with the DNA vaccine between April and June showed a 66% efficacy rate in symptomatic cases, said Sharvil Patel, managing director, Zydus Cadila, There were no cases of death even in moderate to severe cases after the third dose of …

Discover Related